Claudia Gerken

3.2k total citations
14 papers, 789 citations indexed

About

Claudia Gerken is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Claudia Gerken has authored 14 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Claudia Gerken's work include CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (4 papers) and Virus-based gene therapy research (3 papers). Claudia Gerken is often cited by papers focused on CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (4 papers) and Virus-based gene therapy research (3 papers). Claudia Gerken collaborates with scholars based in United States, France and Italy. Claudia Gerken's co-authors include Stephen Gottschalk, Melinda Mata, Cliona M. Rooney, Helen E. Heslop, Giedre Krenciute, Phuong Nguyen, David M. Spencer, Malcolm K. Brenner, Adrian P. Gee and Catherine M. Bollard and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Claudia Gerken

14 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Gerken United States	12	656	294	222	206	164	14	789
Pranay D. Khare United States	10	408 0.6×	197 0.7×	188 0.8×	193 0.9×	139 0.8×	17	701
An Lu United States	10	838 1.3×	400 1.4×	298 1.3×	270 1.3×	323 2.0×	20	949
Tatsunori Goto Japan	14	435 0.7×	240 0.8×	146 0.7×	216 1.0×	163 1.0×	48	723
Claudia Heuser Germany	16	843 1.3×	520 1.8×	209 0.9×	220 1.1×	261 1.6×	19	994
Alexia Ghazi United States	7	498 0.8×	193 0.7×	191 0.9×	202 1.0×	215 1.3×	11	674
Carter M. Suryadevara United States	16	754 1.1×	411 1.4×	171 0.8×	224 1.1×	292 1.8×	31	1.0k
Qiangzhong Ma United States	14	884 1.3×	503 1.7×	274 1.2×	261 1.3×	257 1.6×	18	1.1k
Birju Mehta United States	9	619 0.9×	234 0.8×	234 1.1×	176 0.9×	170 1.0×	17	683
Simon Thomas United Kingdom	10	677 1.0×	201 0.7×	215 1.0×	279 1.4×	266 1.6×	28	773
Jessica Hartmann Germany	16	864 1.3×	483 1.6×	379 1.7×	471 2.3×	168 1.0×	25	1.2k

Countries citing papers authored by Claudia Gerken

Since Specialization

Citations

This map shows the geographic impact of Claudia Gerken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Gerken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Gerken more than expected).

Fields of papers citing papers by Claudia Gerken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Gerken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Gerken. The network helps show where Claudia Gerken may publish in the future.

Co-authorship network of co-authors of Claudia Gerken

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Gerken. A scholar is included among the top collaborators of Claudia Gerken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Gerken. Claudia Gerken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ramos, Carlos A., Mrinalini Bilgi, Claudia Gerken, et al.. (2019). CD30‐CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR THERAPY OF HODGKIN LYMPHOMA (HL). Hematological Oncology. 37(S2). 168–168. 8 indexed citations

Ramos, Carlos A., Mrinalini Bilgi, Claudia Gerken, et al.. (2019). CD30-Chimeric Antigen Receptor (CAR) T Cells for Therapy of Hodgkin Lymphoma (HL). Biology of Blood and Marrow Transplantation. 25(3). S63–S63. 21 indexed citations

Ramos, Carlos A., Mrinalini Bilgi, Claudia Gerken, et al.. (2018). CD30-Chimeric Antigen Receptor (CAR) T Cells for Therapy of Hodgkin Lymphoma (HL). Blood. 132(Supplement 1). 680–680. 23 indexed citations

Mata, Melinda, Claudia Gerken, Phuong Nguyen, et al.. (2017). Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models. Cancer Discovery. 7(11). 1306–1319. 144 indexed citations

Hegde, Meenakshi, Christopher DeRenzo, Huimin Zhang, et al.. (2017). Expansion of HER2-CAR T cells after lymphodepletion and clinical responses in patients with advanced sarcoma.. Journal of Clinical Oncology. 35(15_suppl). 10508–10508. 34 indexed citations

Velasquez, Mireya Paulina, David Torres, Kota Iwahori, et al.. (2016). T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies. Scientific Reports. 6(1). 27130–27130. 45 indexed citations

Mata, Melinda, Juan F. Vera, Claudia Gerken, et al.. (2014). Toward Immunotherapy With Redirected T Cells in a Large Animal Model. Journal of Immunotherapy. 37(8). 407–415. 52 indexed citations

Iwahori, Kota, Sunitha Kakarla, Mireya Paulina Velasquez, et al.. (2014). Engager T Cells: A New Class of Antigen-specific T Cells That Redirect Bystander T Cells. Molecular Therapy. 23(1). 171–178. 81 indexed citations

Krebs, Simone, Kevin Chow, Zhongzhen Yi, et al.. (2014). T cells redirected to interleukin-13Rα2 with interleukin-13 mutein–chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1. Cytotherapy. 16(8). 1121–1131. 63 indexed citations

10.

Salsman, Vita S., Kevin Chow, Donald R. Shaffer, et al.. (2011). Crosstalk between Medulloblastoma Cells and Endothelium Triggers a Strong Chemotactic Signal Recruiting T Lymphocytes to the Tumor Microenvironment. PLoS ONE. 6(5). e20267–e20267. 27 indexed citations

11.

Louis, Chrystal U., Karin Straathof, Catherine M. Bollard, et al.. (2010). Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma. Journal of Immunotherapy. 33(9). 983–990. 160 indexed citations

12.

Louis, Chrystal U., Karin Straathof, Claudia Gerken, et al.. (2008). 244: Treatment of Epstein Barr Virus Positive Nasopharyngeal Carcinoma with Adoptively Transferred Cytotoxic T Lymphocytes. Biology of Blood and Marrow Transplantation. 14(2). 90–90. 1 indexed citations

13.

Louis, Chrystal U., Karin Straathof, Catherine M. Bollard, et al.. (2008). Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients. Blood. 113(11). 2442–2450. 83 indexed citations

14.

Xu, Huansheng, et al.. (2006). Tbx1 regulates population, proliferation and cell fate determination of otic epithelial cells. Developmental Biology. 302(2). 670–682. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact